Goodwin Guy
Known title: Chief Medical OfficerCIK: 0001898328
Associated companies
Transaction History
| CMPS | ▲ Buy | Grant | 8,000 | $0 | 2/1/2022 | View on chart |
| CMPS | ▲ Buy | Grant | 8,000 | $0 | 2/1/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Compass Pathways Q2 2026 Earnings Released Amid Low RSI
Compass Pathways has released its Q2 2026 results, providing the latest financial update for the company. The news cycle also includes broader sector commentary on pipeline risks, though specific details for Compass remain focused on the earnings release. The stock is currently trading near its 52-week low, reflecting recent market sentiment.
Compass Pathways Q2 2026 Earnings Released Amid Low RSI. Compass Pathways has released its Q2 2026 results, providing the latest financial update for the company. The news cycle also includes broader sector commentary on pipeline risks, though specific details for Compass remain focused on the earnings release. The stock is currently trading near its 52-week low, reflecting recent market sentiment.